—While testing companies may differ, most physicians will run the same panels for their non-small cell lung cancer patients, explains Laurie Matt-Amaral, MD, of Cleveland Clinic. (1:39) NSCLC ...
Biomarker testing has become “increasingly critical” in the care of non-small cell lung cancer.A new investigation into testing rates proved “reassuring” to Kenneth L. Kehl, MD, MPH, assistant ...
"Clinicians performing tumor biopsy need to ensure that there’s adequate tissue for both diagnosis and NGS testing. Having immediate pathology review of biopsy specimens in the operating room can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback